11926 related articles for article (PubMed ID: 11706558)
1. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1.
Ishii S; Han S; Shiiba K; Mizoi T; Okabe M; Horii A; Nagura H; Matsuno S; Sasaki I
Int J Clin Oncol; 2001 Aug; 6(4):201-4. PubMed ID: 11706558
[TBL] [Abstract][Full Text] [Related]
2. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
4. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.
Gutzmer R; Herbst RA; Mommert S; Kiehl P; Matiaske F; Rütten A; Kapp A; Weiss J
Hum Genet; 2000 Oct; 107(4):357-61. PubMed ID: 11129335
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
[TBL] [Abstract][Full Text] [Related]
7. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
Legius E; Marchuk DA; Collins FS; Glover TW
Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
9. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
Güran S; Safali M
Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
[TBL] [Abstract][Full Text] [Related]
12. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
Thomas L; Mautner VF; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Sep; 6(1):18. PubMed ID: 23244685
[TBL] [Abstract][Full Text] [Related]
13. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
[TBL] [Abstract][Full Text] [Related]
14. Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene.
Oguzkan S; Terzi YK; Güler E; Derbent M; Agras PI; Saatci U; Ayter S
Cancer Genet Cytogenet; 2006 Jan; 164(2):159-63. PubMed ID: 16434322
[TBL] [Abstract][Full Text] [Related]
15. Malignant pheochromocytoma in a 16-year-old patient with neurofibromatosis type 1.
Giovannoni I; Callea F; Boldrini R; Inserra A; Cozza R; Francalanci P
Pediatr Dev Pathol; 2014; 17(2):126-9. PubMed ID: 24555864
[TBL] [Abstract][Full Text] [Related]
16. Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1.
Yap P; Super L; Qin J; Burgess T; Prodanovic Z; Edwards C; Thomas R; Carpenter K; Tan TY
Pediatr Blood Cancer; 2016 Apr; 63(4):706-8. PubMed ID: 26514327
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
Kluwe L; Friedrich RE; Mautner VF
Cancer Genet Cytogenet; 1999 Aug; 113(1):65-9. PubMed ID: 10459349
[TBL] [Abstract][Full Text] [Related]
18. Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1.
Courtney E; Chan SH; Li ST; Ishak D; Merchant K; Shaw T; Chay WY; Chin FHX; Wong WL; Wong A; Ngeow J
Fam Cancer; 2020 Oct; 19(4):353-358. PubMed ID: 32405727
[TBL] [Abstract][Full Text] [Related]
19. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
